oral dosage articles & resources on Made-in-China.com

Australia's Pharmapak Technologies Is Acquired by Catalent

Apr 1, 2015

Catalent Pharma Solutions, a US-based provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has acquired Australian pharmaceutical packaging business, Pharmapak Technologies, ...

Tags: delivery technologies, Pacific, Packaging

USPTO Has Granted a Patent to Atlantic Pharma for Drug Delivery System

Aug 26, 2013

The US Patent and Trademark Office (USPTO) has granted a patent to Atlantic Pharma for its SMART/Script abuse deterrent drug delivery system. Designed to thwart dose dumping of orally delivered prescription opioids, the new drug delivery ...

Tags: Atlantic Pharma, Medicine

Alitair Pharmaceuticals Has Retained Finn, Warnke & Gayton to Sell Two Alitair Patents

Apr 15, 2013

US-based Alitair Pharmaceuticals has retained Finn, Warnke & Gayton to sell two Alitair patents and an associated royalty stream at a sealed bid sale on 24 May 2013. The first patent, which was issued in 2012, covers the use of ion ...

Tags: Alitair Pharmaceuticals, Health, Medicine

Almac Cleared The FDA Inspection and Begun US Commercial Packaging Operations in Audubon

Feb 7, 2013

Almac has cleared the FDA inspection and begun US commercial packaging operations in Audubon, Pennsylvania. The FDA concluded that the site is compliant with good manufacturing practices, with no 483 issued. Almac quality vice president ...

Tags: FDA, Almac Pennsylvania Packaging Facility, Medicivne

Teva Has Decided Not to Launch Atorvastatin, a Generic Version of Pfizer's Lipitor.

Nov 28, 2012

Teva Pharmaceutical Industries has decided not to launch atorvastatin, a generic version of Pfizer's Lipitor. The decision will help Ranbaxy Laboratories and Dr Reddy's Laboratories gain larger sales of the medicine in the US, the ...

Tags: Generic Lipitor, oral dosage, company's strategy

USPTO Has Issued a Patent Entitled, Abuse-Resistant Oral Dosage Forms and Method

May 23, 2012

The United States Patent and Trademark Office (USPTO) has issued a patent entitled, Abuse-Resistant Oral Dosage Forms and Method of Use Thereof, to Elite Pharmaceuticals. The patent will protect the Elite's proprietary formulation for ...

Tags: USPTO, Elite Pharmaceuticals, proprietary formulation

oral dosage